Bridging The Gap: Key Considerations In Biologic Technology Transfer

The development and production of biologics is a complex journey that often necessitates collaboration between different organizations. This collaboration can take many forms, from transitioning a biologic from research to development, from development to full-scale manufacturing, or even between different manufacturing facilities. This critical step, known as technology transfer, is essential for guaranteeing the successful production of biologics that meet the highest quality standards.

A well-executed technology transfer relies on meticulous planning, collaboration with a team of experts with diverse skillsets, and a focused and purposeful approach. In this article, we delve into nine key considerations involved in successfully transferring the technology behind monoclonal antibodies.